Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Michaelis

Showing results (141-150 of 214) with videos related to

Pageof 22
Sort By:
Journal of Translational Medicine|December 14, 2017
Sprifermin (rhFGF18) modulates extracellular matrix turnover in cartilage explants ex vivoDitte Reker, Cecilie F Kjelgaard-Petersen, Anne Sofie Siebuhr, et al.
Molecular Oncology|October 1, 2022
ERBB and P-glycoprotein inhibitors break resistance in relapsed neuroblastoma models through P-glycoproteinLisa Rösch, Sonja Herter, Sara Najafi, et al.
International Journal of Molecular Sciences|August 23, 2020
The Anti-ADAMTS-5 Nanobody<sup>®</sup> M6495 Protects Cartilage Degradation Ex VivoAnne Sofie Siebuhr, Daniela Werkmann, Anne-C Bay-Jensen, et al.
Cells|December 22, 2019
The Thrombopoietin Receptor Agonist Eltrombopag Inhibits Human Cytomegalovirus Replication Via Iron ChelationJens-Uwe Vogel, Sophie Schmidt, Daniel Schmidt, et al.
Oncology Letters|November 9, 2017
Blocking integrin β1 decreases adhesion in chemoresistant urothelial cancer cell linesStefan Vallo, Jochen Rutz, Miriam Kautsch, et al.
Oncotarget|February 18, 2016
Substrate-specific effects of pirinixic acid derivatives on ABCB1-mediated drug transportMartin Michaelis, Florian Rothweiler, Mario Wurglics, et al.
Cancer Letters|June 13, 2017
The small molecule inhibitor YK-4-279 disrupts mitotic progression of neuroblastoma cells, overcomes drug resistance and synergizes with inhibitors of mitosisMadhu Kollareddy, Alice Sherrard, Ji Hyun Park, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 27, 2016
Utilising the EGFR interactome to identify mechanisms of drug resistance in non-small cell lung cancer - Proof of concept towards a systems pharmacology approachHisham Saafan, Sarah Foerster, Zinnia P Parra-Guillen, et al.
International Journal of Oncology|September 6, 2005
Increased malignant behavior in neuroblastoma cells with acquired multi-drug resistance does not depend on P-gp expressionRouslan Kotchetkov, Pablo Hernáiz Driever, Jaroslav Cinatl, et al.
Plos One|July 27, 2017
Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrestNavin Sarin, Florian Engel, Ganna V Kalayda, et al.
Pageof 22

Showing results (141-150 of 214) with videos related to

Sort By:
Pageof 22
Journal of Translational Medicine|December 14, 2017
Sprifermin (rhFGF18) modulates extracellular matrix turnover in cartilage explants ex vivoDitte Reker, Cecilie F Kjelgaard-Petersen, Anne Sofie Siebuhr, et al.
Molecular Oncology|October 1, 2022
ERBB and P-glycoprotein inhibitors break resistance in relapsed neuroblastoma models through P-glycoproteinLisa Rösch, Sonja Herter, Sara Najafi, et al.
International Journal of Molecular Sciences|August 23, 2020
The Anti-ADAMTS-5 Nanobody<sup>®</sup> M6495 Protects Cartilage Degradation Ex VivoAnne Sofie Siebuhr, Daniela Werkmann, Anne-C Bay-Jensen, et al.
Cells|December 22, 2019
The Thrombopoietin Receptor Agonist Eltrombopag Inhibits Human Cytomegalovirus Replication Via Iron ChelationJens-Uwe Vogel, Sophie Schmidt, Daniel Schmidt, et al.
Oncology Letters|November 9, 2017
Blocking integrin β1 decreases adhesion in chemoresistant urothelial cancer cell linesStefan Vallo, Jochen Rutz, Miriam Kautsch, et al.
Oncotarget|February 18, 2016
Substrate-specific effects of pirinixic acid derivatives on ABCB1-mediated drug transportMartin Michaelis, Florian Rothweiler, Mario Wurglics, et al.
Cancer Letters|June 13, 2017
The small molecule inhibitor YK-4-279 disrupts mitotic progression of neuroblastoma cells, overcomes drug resistance and synergizes with inhibitors of mitosisMadhu Kollareddy, Alice Sherrard, Ji Hyun Park, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 27, 2016
Utilising the EGFR interactome to identify mechanisms of drug resistance in non-small cell lung cancer - Proof of concept towards a systems pharmacology approachHisham Saafan, Sarah Foerster, Zinnia P Parra-Guillen, et al.
International Journal of Oncology|September 6, 2005
Increased malignant behavior in neuroblastoma cells with acquired multi-drug resistance does not depend on P-gp expressionRouslan Kotchetkov, Pablo Hernáiz Driever, Jaroslav Cinatl, et al.
Plos One|July 27, 2017
Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrestNavin Sarin, Florian Engel, Ganna V Kalayda, et al.
Pageof 22